Clinical trial NCT02715349: Psychoeducation for Vietnamese Families With a Patient With Schizophrenia
Official title: Psychoeducation for Vietnamese Families With a Patient With Schizophrenia
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Schizophrenia
Keywords: schizophrenia
psychoeducation
Vietnam
Lead sponsor: Danang Psychiatric Hospital
Sponsor class: OTHER
First posted: 2016-03-22
Enrollment: 59
Sex: ALL
Minimum age (years): 18
Maximum age (years): 30
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Families with a patient with schizophrenia and the patient are randomly assigned to receive either a 3 session psychoeducation program, or no psychoeducation. Other treatment for schizophrenia and other mental illness are provided as usual.

Detailed description: Families with a patient with schizophrenia and the patient are randomly assigned to receive either a 3 session psychoeducation program, or no psychoeducation. Other treatment for schizophrenia and other mental illness are provided as usual. The psychoeducation program focuses on: (a) explaining schizophrenia as a medical, biological illness, (b) the prognosis for schizophrenia (e.g., that it is possible to lead a normal life), and (c) what the family and patient can do to maximize the outcome.

Eligibility criteria: Inclusion Criteria:

* Diagnosis of schizophrenia, based on ICD-10
* Receive in-patient treatment at hospital
* Length of schizophrenia less than 3 years.
* Treated 3 or less times for schizophrenia.

Exclusion Criteria:

* Mental retardation, or other diagnoses that could affect the ability to answer questionnaires, after the acute schizophrenia psychosis is controlled.
* Suicidal ideation

Primary outcomes:
measure: Change from baseline (pre-treatment) to 6 months post-baseline in patient-report of quality of life using the Quality of Life Enjoyment and Satisfaction Questionnaire.
timeFrame: baseline (pre-treatment). six months post-baseline.
measure: Change from baseline (pre-treatment) at 6 months post-baseline in family-report of quality of life using the Quality of Life Enjoyment and Satisfaction Questionnaire.
timeFrame: baseline (pre-treatment). six months post-baseline.
Secondary outcomes:
measure: Change from baseline (pre-treatment) to 6 months post-baseline in patient-report of stigma towards schizophrenia using the Stigma Towards Schizophrenia questionnaire.
timeFrame: baseline (pre-treatment). six months post-baseline.
measure: Change from baseline (pre-treatment) to 6 months post-baseline in family-report of stigma towards schizophrenia using the Stigma Towards Schizophrenia questionnaire.
timeFrame: baseline (pre-treatment). six months post-baseline.
measure: Patient-report for schizophrenia medication compliance, at 6 months post-baseline
timeFrame: 6 months post-baseline
Other outcomes:
measure: Patient-report satisfaction with hospital services, at 6 months post-baseline
timeFrame: 6 months post-baseline
measure: Family-report satisfaction with hospital services, at 6 months post-baseline
timeFrame: 6 months post-baseline
Locations:
city: Danang
country: Vietnam
facility: Danang Psychiatric Hospital
Study officials:
affiliation: Danang Psychiatric Hospital
name: Ngoc Tran, MD
role: PRINCIPAL_INVESTIGATOR
References: